Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 125.50p 124.00p 127.00p 125.50p 125.50p 125.50p 14,903 07:45:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 165.6 8.4 6.3 20.0 132

Cello Health Share Discussion Threads

Showing 1026 to 1049 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
21/7/2019
13:31
getting good coverage on stockopedia as a solid div growth payer
gutterhead
18/7/2019
19:20
nice uptick today. A guarded upgrade IMO, yet market hasn't really digested it....more to come, maybe increase in divi? DYOR
qs99
18/7/2019
12:02
Yes, that is possible, QS. A win either way, atm.
poikka
18/7/2019
10:26
if that is an average of the peer group, how long before someone takes "a look" at CLL? or management get bored with the share price and do something about it?! DYOR
qs99
18/7/2019
10:22
Picked some of these up first thing. The stock has fallen from recent highs just under 140 for no reason. Trading is strong and warrants a move back up on unjustified market jitters. "At least in line", which basically means they're ahead and forecasts will be upgraded. FinnCap are also alluding to this, but have not changed forecasts yet. Stock is up 7% at present as Mr Market isn't waiting about for that upgrade, price it in ahead. Here's FinnCap: "Cello’s Health division has had an “excellentR21;first half with strong like-for-like, constant currency revenue growth. Operating margins are ahead of last year and the group has also benefited from stronger US$ exchange rates in H1. Coupled with a good current income pipeline,these points have enabled management to state it is confident of achieving a successful result in 2019, at least in line with current market expectations. We make no changes to our forecasts at this stage, although the potential foran upgrade is clearly growing.Encouraged by today’s statement, we reiterate our view that the market backdrop for Cello’s technically based, strategic advisory services is strong and defensive, supporting good growth prospects." "Valued at a discount to peers.The potential for above average long-term growth(both organically and by acquisitions which Cello continues to assess)in a defensive market means the peer group is highlyrated at an average P/E of 24.7x in FY 2019, including UK quoted peer UDG at 21x. Cello isvalued at a FY 2019 P/E of 13.2x" This will get tasty if it can breakthrough 140 in the future. Let's see how we get on.
sphere25
18/7/2019
09:29
Yes, the outlook was more upbeat than the finals
zipstuck
18/7/2019
08:41
Good update, and nothing to add other than nice to see a ray of sunshine in the global gloom.
poikka
02/7/2019
12:45
They sold 600,000 out of 950,000 options vested. A bit more than covering their tax!
coopstock
02/7/2019
11:47
Good point zipstuck
barnesian
02/7/2019
11:22
I think the share option message is that when they sell part of the options they are selling to cover the tax and NI costs. In effect they are adding so I'm happy to hold
zipstuck
28/6/2019
13:53
Poor response - filtered.
poikka
28/6/2019
10:34
It's happened three years running and it'll happen again next time - but of course you boys know best...
coopstock
28/6/2019
10:26
Well yes, it doesn't help, but I doubt that it added any pressure to the share price At least they only flogged just over half of those shares, except for the FD, wasn't it. Still, agree with your comments. Yesterday's fall was quite dramatic, and hopefully due to a rubbish trade. Maybe more small company OIECs trying to avoid Woody's woes. Best to avoid small company ITs for a while, I guess, having only recently bought some EWI and JMI..
poikka
28/6/2019
08:20
Badly executed sell? Buying opportunity?
poikka
27/6/2019
18:55
No, I can't see that Woddford PC holds any, or didn't at the Finals.
poikka
27/6/2019
18:49
WTF! Woodford flogging some? Anyone got any news? Coopstock, what do you mean "more dilution"?
poikka
25/6/2019
09:10
More dilution and more pressure on the share price just when we don’t need it
coopstock
15/5/2019
08:16
Kabouter? Never heard of them, but nice to see that they like us :)
poikka
21/3/2019
21:34
That is true (Cenkos), but that growth is taking a long time to come. But then I've held them for 9 years.
poikka
21/3/2019
10:44
Cenkos; Organic momentum continues Today’s largely in-line results were well flagged by January’s trading update, but there are notable beats on EPS, DPS and Net cash. The group continues its organically focused delivery, leveraging Signal’s digital capabilities into the healthcare space, alongside new office openings. This will continue Cello’s migration over time into a more healthcare-focused, US-centric and higher margin business. We feel the defensive nature and FCF potential of Cello are not fairly valued in the current share price.
davebowler
21/3/2019
08:06
Ok, not startling. Growth hard to come by. Think I'll hold.
poikka
04/2/2019
15:20
Cello Health will be presenting to investors at the upcoming Proactive One2One Forum on Thursday 7th Fhttps://images.advfn.com/imagesnew/2/gb/nl/postreply.gifebruary. Details and registration: https://tinyurl.com/ya52v872
aim_trader
23/1/2019
14:14
I guess the weakness is due to the slower Signal and charge this year for closing Cheltenham.
zipstuck
21/1/2019
09:20
Reasonable divi with some growth to come
zipstuck
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190723 01:55:42